Europe Cell Therapy Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Therapy Type (Allogeneic, Autologous); Product (Consumables, Equipment, Systems and Software); Technology (Viral Vector Technology, Genome Editing Technology, Somatic Cell Technology, Cell Immortalization Technology, Cell Plasticity Technology, Three-dimensional Technology); Application (Oncology, Cardiovascular, Orthopedic, Wound Management, Other Applications); End User (Research Institutes, Hospitals, Others), and Country.
Market Introduction
Cell therapy is a procedure where living and intact cells are injected, implanted, or grafted into the patient's body. This technology relies on replacing dysfunctional cells with healthy functioning ones. Cells mainly used for such advanced therapies are stem cells, because of their ability to differentiate into the specific cells required for repairing damaged or defective tissues or cells. Moreover, cell therapy also has applications in the development of regenerative medicines. Increasing prevalence of chronic diseases, rising adoption of regenerative medicines, and increasing number of approvals for cell-based therapies is likely to drive the growth of the Cell therapy market during the forecast period.
Market Dynamics
The Europe Cell therapy market is expected to reach US$ 3,610.7 million by 2027 from US$ 2,125.7 million in 2019; it is anticipated to grow at a CAGR of 6.9% during 2019–2027. Factors such as Increasing prevalence of chronic diseases, rising adoption of regenerative medicines, and increasing number of approvals for cell-based therapies are expected to boost the growth of the Cell therapy market in the coming years. However, the market is likely to get impacted by the risk factor such as high cost of cell therapy manufacturing in emerging countries during the forecast period.
COVID-19 pandemic has become the most significant challenge across the Europe region. The cell therapy instrument market witnessed some shortfall at the beginning of COVID-19 crisis owing to factors such as disruption in supply chain and demand due to lock down announced by majority of European countries. However, the demand for the cell therapy increased drastically owing to supportive government initiatives.
Market Scope
The scope of the Europe Cell therapy market includes therapy type, product, technology, application, end user and country. In terms of therapy types, in 2019, the allogeneic segment accounted for the highest share owing to the availability of substantial number of approved products for clinical use. However, the autologous segment is also likely to register the highest CAGR in the market during the forecast period.
Major Sources and Companies Listed
Several major primary and secondary sources associated with the Europe Cell therapy market report are the World Health Organization (WHO), European Centre for Disease Prevention and Control (ECDC), Alliance for Regenerative Medicine, National Institutes of Health, Anthony Nolan Foundation, among others.
Reasons to Buy Report
- It provides understanding of the Europe, Cell therapy market landscape and identifies Cell therapy market segments that are most likely to guarantee a strong return.
- It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the Europe Cell therapy market.
- It helps efficiently plan merger and acquisition, and partnership deals in the Cell therapy market by identifying market segments with the most promising probable sales.
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of Cell therapy market performance of various segments pertaining to the Europe Cell therapy market.
- It provides Cell therapy market revenue forecast of the market based on various segments for the period from 2019 to 2027.
EUROPE CELL THERAPY MARKET SEGMENTATION
By Therapy Type
- Allogeneic
- Autologous
By Product
- Consumables
- Equipment
- Systems and Software
By Technology
- Viral Vector Technology
- Genome Editing Technology
- Somatic Cell Technology
- Cell Immortalization Technology
- Cell Plasticity Technology
- Three-Dimensional Technology
By Application
- Oncology
- Cardiovascular
- Orthopedic
- Wound Management
- Other Applications
By End User
- Research Institutes
- Hospitals
- Others
By Country
- Germany
- France
- Italy
- UK
- Spain
Company Profiles
- Vericel Corporation
- MEDIPOST
- NuVasive, Inc.
- Mesoblast Limited
- Smith & Nephew
- Bristol-Myers Squibb Company
- Cells for Cells
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Cell Therapy Market – By Therapy Type
1.3.2 Europe Cell Therapy Market – By Product
1.3.3 Europe Cell Therapy Market – By Technology
1.3.4 Europe Cell Therapy Market – By Application
1.3.5 Europe Cell Therapy Market – By End User
1.3.6 Europe Cell Therapy Market – By Geography
2. Cell Therapy Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Cell therapy– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe– PEST Analysis
Expert Opinions
5. Europe Cell Therapy Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Rising Adoption of Regenerative Medicines
5.1.3 Increasing Number of Approvals for Cell-Based Therapies
5.2 Key Market Restraints
5.2.1 High Cost of Cell Therapy Manufacturing
5.3 Key Market Opportunities
5.3.1 Increasing focus on personalized medicine
5.4 Future Trends
5.4.1 Shift Toward Automated Cell Therapy Manufacturing
5.5 Impact Analysis of Drivers and Restraints
6. Cell therapy Market – Europe Analysis
6.1 Europe Cell therapy Market Revenue Forecast And Analysis
7. Cell therapy Market Analysis – By Therapy Type
7.1 Overview
7.2 Cell therapy Market Revenue Share, by Therapy Type (2019 and 2027)
7.3 Allogeneic
7.3.1 Overview
7.3.2 Allogeneic: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Autologous
7.4.1 Overview
7.4.2 Autologous: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
8. Cell therapy Market Analysis – By Product
8.1 Overview
8.2 Cell therapy Market Revenue Share, by Product (2019 and 2027)
8.3 Consumables
8.3.1 Overview
8.3.2 Consumables: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Equipment
8.4.1 Overview
8.4.2 Equipment: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Systems and Software
8.5.1 Overview
8.5.2 Systems and Software: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
9. Cell therapy Market Analysis – By Technology
9.1 Overview
9.2 Cell therapy Market Revenue Share, by Technology (2019 and 2027)
9.3 Viral Vector Technology
9.3.1 Overview
9.3.2 Viral Vector Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Genome Editing Technology
9.4.1 Overview
9.4.2 Genome Editing Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Somatic Cell Technology
9.5.1 Overview
9.5.2 Somatic Cell Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
9.6 Cell Immortalization Technology
9.6.1 Overview
9.6.2 Cell Immortalization Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
9.7 Cell Plasticity Technology
9.7.1 Overview
9.7.2 Cell Plasticity Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
9.8 Three-Dimensional Technology
9.8.1 Overview
9.8.2 Three-Dimensional Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
10. Cell therapy Market Analysis – By Application
10.1 Overview
10.2 Cell therapy Market Revenue Share, by Application (2019 and 2027)
10.3 Oncology
10.3.1 Overview
10.3.2 Oncology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
10.4 Cardiovascular
10.4.1 Overview
10.4.2 Cardiovascular: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
10.5 Orthopedic
10.5.1 Overview
10.5.2 Orthopedic: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
10.6 Wound Management
10.6.1 Overview
10.6.2 Wound Management: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
10.7 Other Applications
10.7.1 Overview
10.7.2 Other Applications: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
11. Cell therapy Market Analysis – By End User
11.1 Overview
11.2 Cell therapy Market Share, by End User, 2019 and 2027, (%)
11.3 Hospitals
11.3.1 Overview
11.3.2 Hospitals: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
11.4 Research Institutes
11.4.1 Overview
11.4.2 Research Institutes: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
12. Cell therapy Market – Geographic Analysis
12.1 Europe: Cell therapy Market
12.1.1 Overview
12.1.2 Europe: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.3 Europe: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
12.1.4 Europe: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
12.1.5 Europe: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
12.1.6 Europe: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
12.1.7 Europe: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
12.1.8 Europe: Cell therapy Market, by Country, 2019 & 2027 (%)
12.1.9 Germany: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.9.1 Germany: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.9.2 Germany: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
12.1.9.3 Germany: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
12.1.9.4 Germany: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
12.1.9.5 Germany: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
12.1.9.6 Germany: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
12.1.10 France: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.10.1 France: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.10.2 France: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
12.1.10.3 France: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
12.1.10.4 France: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
12.1.10.5 France: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
12.1.10.6 France: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
12.1.11 UK: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.11.1 UK: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.11.2 UK: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
12.1.11.3 UK: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
12.1.11.4 UK: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
12.1.11.5 UK: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
12.1.11.6 UK: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
12.1.12 Italy: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.12.1 Italy: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.12.2 Italy: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
12.1.12.3 Italy: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
12.1.12.4 Italy: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
12.1.12.5 Italy: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
12.1.12.6 Italy: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
12.1.13 Spain: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.13.1 Spain: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.13.2 Spain: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
12.1.13.3 Spain: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
12.1.13.4 Spain: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
12.1.13.5 Spain: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
12.1.13.6 Spain: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
13. Impact of COVID-19 Pandemic on Europe Cell Therapy Market
13.1 Europe: Impact Assessment of COVID-19 Pandemic
14. Cell Therapy Market– Industry Landscape
14.1 Overview
14.2 Growth Strategies Done by the Companies in the Market, (%)
14.3 Organic Developments
14.3.1 Overview
14.4 Inorganic Developments
14.4.1 Overview
15. Company Profiles
15.1 Vericel Corporation
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 MEDIPOST
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 NuVasive, Inc.
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Mesoblast Limited
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Smith & Nephew
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Bristol-Myers Squibb Company
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Cells for Cells
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Stemedica Cell Technologies, Inc
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
16. Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
Table 2. Europe: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 3. Europe: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 4. Europe: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 5. Europe: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
Table 6. Germany: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
Table 7. Germany: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 8. Germany: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 9. Germany: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 10. Germany: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
Table 11. France: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
Table 12. France: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 13. France: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 14. France: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 15. France: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
Table 16. UK: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
Table 17. UK: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 18. UK: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 19. UK: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 20. UK: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
Table 21. Italy: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
Table 22. Italy: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 23. Italy: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 24. Italy: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 25. Italy: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
Table 26. Spain: Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
Table 27. Spain: Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 28. Spain: Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 29. Spain: Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 30. Spain: Cell Therapy Market, By End User – Revenue and Forecast to 2027 (USD Million)
Table 31. Organic Developments Done By Companies
Table 32. Inorganic Developments Done By Companies
Table 33. Glossary of Terms, Cell therapy Market
LIST OF FIGURES
Figure 1. Cell Therapy Market Segmentation
Figure 2. Cell Therapy Market, By Region
Figure 3. Europe Cell Therapy Market Overview
Figure 4. The Autologous Segment Is Expected To Grow Faster By Therapy Type Segment In Cell therapy Market
Figure 5. Europe Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe Cell therapy Market- Leading Country Markets (USD Million)
Figure 7. Europe PEST Analysis
Figure 8. Cell Therapy Market Impact Analysis of Driver and restraint
Figure 9. Europe Cell therapy Market – Revenue Forecast And Analysis – 2019- 2027
Figure 10. Cell therapy Market Revenue Share, by Therapy Type (2019 and 2027)
Figure 11. Allogeneic: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Autologous: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Cell therapy Market Revenue Share, by Product (2019 and 2027)
Figure 14. Consumables: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Equipment: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Systems and Software: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Cell therapy Market Revenue Share, by Technology (2019 and 2027)
Figure 18. Viral Vector Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Genome Editing Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Somatic Cell Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Cell Immortalization Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Cell Plasticity Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Three-Dimensional Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Cell therapy Market Revenue Share, by Application (2019 and 2027)
Figure 25. Oncology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Cardiovascular: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Orthopedic: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 28. Wound Management: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 29. Other Applications: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 30. Cell therapy Market Share, by End User, 2019 and 2027 (%)
Figure 31. Hospitals Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 32. Research Institutes: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 33. Others: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 34. Europe: Cell therapy Market, by Key Country – Revenue (2019) (USD Million)
Figure 35. Europe: Cell Therapy Market Revenue and Forecast to 2027 (USD Million)
Figure 36. Europe: Cell therapy Market, by Country, 2019 & 2027 (%)
Figure 37. Germany: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. France: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
Figure 39. UK: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
Figure 40. Italy: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
Figure 41. Spain: Cell therapy Market – Revenue and Forecast to 2027 (USD Million)
Figure 42. Impact of COVID-19 Pandemic in European Country Markets
Figure 43. Growth Strategies Done by the Companies in the Market, (%)
- Vericel Corporation
- MEDIPOST
- NuVasive, Inc.
- Mesoblast Limited
- Smith & Nephew
- Bristol-Myers Squibb Company
- Cells for Cells
- Stemedica Cell Technologies, Inc.
- It provides understanding of the Europe, Cell therapy market landscape and identifies Cell therapy market segments that are most likely to guarantee a strong return.
- It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the Europe Cell therapy market.
- It helps efficiently plan merger and acquisition, and partnership deals in the Cell therapy market by identifying market segments with the most promising probable sales.
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of Cell therapy market performance of various segments pertaining to the Europe Cell therapy market.
- It provides Cell therapy market revenue forecast of the market based on various segments for the period from 2019 to 2027.